Basso D - Search Results

1

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.

Campa D, Obazee O, Pastore M, Panzuto F, Liço V, Greenhalf W, Katzke V, Tavano F, Costello E, Corbo V, Talar-Wojnarowska R, Strobel O, Zambon CF, Neoptolemos JP, Zerboni G, Kaaks R, Key TJ, Lombardo C, Jamroziak K, Gioffreda D, Hackert T, Khaw KT, Landi S, Milanetto AC, Landoni L, Lawlor RT, Bambi F, Pirozzi F, Basso D, Pasquali C, Capurso G, Canzian F. Campa D, et al. Among authors: basso d. Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1349-1351. doi: 10.1158/1055-9965.EPI-17-0075. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28765340

2

How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?

Basso D, Fabris C, Del Favero G, Piccoli A, Angonese C, Pasquali C, Castoro C, Plebani M, Leandro G, Burlina A, et al. Basso D, et al. Ital J Gastroenterol. 1990 Feb;22(1):1-6. Ital J Gastroenterol. 1990. PMID: 2131920

3

[Ca 19-9 in the diagnosis of pancreatic carcinoma].

Meggiato T, Basso D, Pasquali C, Angonese C, Bellinvia S, Del Favero G, Fabris C, Di Mario F, Plebani M, Pedrazzoli S, et al. Meggiato T, et al. Among authors: basso d. Minerva Med. 1989 May;80(5):431-4. Minerva Med. 1989. PMID: 2747969 Italian.

4

Diabetes mellitus in pancreatic cancer follow-up.

Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D'Angeli F, Del Favero G, Plebani M. Fogar P, et al. Among authors: basso d, d angeli f. Anticancer Res. 1994 Nov-Dec;14(6B):2827-30. Anticancer Res. 1994. PMID: 7532931 Clinical Trial.

5

Is CA242 really a new tumour marker for pancreatic adenocarcinoma?

Plebani M, Basso D, Navaglia F, D'Angeli F, Panozzo MP, Del Giudice G, Battistel M, Meggiato T, Del Favero G. Plebani M, et al. Among authors: basso d, d angeli f. Oncology. 1995 Jan-Feb;52(1):19-23. doi: 10.1159/000227421. Oncology. 1995. PMID: 7800337

6

Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer.

Plebani M, Basso D, Del Favero G, Ferrara C, Meggiato T, Fogar P, Mangano F, Ricciardi G, Burlina A. Plebani M, et al. Among authors: basso d. Oncology. 1993 Nov-Dec;50(6):436-40. doi: 10.1159/000227225. Oncology. 1993. PMID: 8233283

7

Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias.

Fogar P, Basso D, Pasquali C, De Paoli M, Sperti C, Roveroni G, Pedrazzoli S, Plebani M. Fogar P, et al. Among authors: basso d. Anticancer Res. 1997 Mar-Apr;17(2B):1227-30. Anticancer Res. 1997. PMID: 9137477

8

Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer.

Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, De Paoli M, Galeotti F, Corsini A, Plebani M. Fogar P, et al. Among authors: basso d. Clin Chim Acta. 1998 Oct;277(2):181-9. doi: 10.1016/s0009-8981(98)00125-9. Clin Chim Acta. 1998. PMID: 9853701

9

ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications.

Zambon C, Navaglia F, Basso D, Gallo N, Greco E, Piva MG, Fogar P, Pasquali C, Pedrazzoli S, Plebani M. Zambon C, et al. Among authors: basso d. Clin Chim Acta. 2000 Dec;302(1-2):35-48. doi: 10.1016/s0009-8981(00)00351-x. Clin Chim Acta. 2000. PMID: 11074062

10

CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging.

Piva MG, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, Zambon CF, Pedrazzoli S, Plebani M. Piva MG, et al. Among authors: basso d. Oncology. 2000 Nov;59(4):323-8. doi: 10.1159/000012190. Oncology. 2000. PMID: 11096345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page